Glenmede Trust CO Na Geron Corp Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.05 $1,550 - $2,050	-1,000 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$3.29 - $4.82 $3,290 - $4,820	1,000 New	1,000 $3,000
Q4 2017 Feb 15, 2018	SELL	$1.8 - $2.32 $1,800 - $2,320	-1,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.99 - $2.65 $1,990 - $2,650	1,000	1,000 $0

259

450M

1.91M

897K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.